Angiocidin (human) (rec.) (untagged)

AdipoGen Life Sciences

Angiocidin (human) (rec.) (untagged)

10

Research Use Only

0.1 mg/ml

>95%

PSMD4

proteasome 26S subunit ubiquitin receptor, non-ATPase 4

AF, AF-1, ASF, MCB1, Rpn10, S5A, pUB-R5, 26S proteasome non-ATPase regulatory subunit 4, 26S proteasome regulatory subunit S5A, S5a/antisecretory factor protein, angiocidin, antisecretory factor 1, multiubiquitin chain-binding protein, proteasome (prosome, macropain) 26S subunit, non-ATPase, 4, proteasome 26S subunit, non-ATPase 4

26S proteasome non-ATPase regulatory subunit 4

Angiocidin shows sequence similarity with proteasome components and is also being referred to as 26A proteasome regulatory subunit S5A. Angiocidin shows both matrix and cytoplasmic distribution. It binds to thrombospondin-1 and alpha2beta1 integrin, and it inhibits tumor progression and angiogenesis. Angiocidin is expressed in various types of cancer, such as hepatocellular carcinoma, prostate, lung, bladder, and melanoma cancers. - Protein. Human angiocidin (aa 2-377) is untagged. Source: E. coli. Endotoxin content: 95% (SDS-PAGE). Angiocidin shows sequence similarity with proteasome components and is also being referred to as 26A proteasome regulatory subunit S5A. Angiocidin shows both matrix and cytoplasmic distribution. It binds to thrombospondin-1 and alpha2beta1 integrin, and it inhibits tumor progression and angiogenesis. Angiocidin is expressed in various types of cancer, such as hepatocellular carcinoma, prostate, lung, bladder, and melanoma cancers.

-20°C,2°C to 8°C

41116100

Human